Ryan Thomas is the chair of the firm’s Private Equity Team and co-chair of the Healthcare Private Equity Team. As mergers and acquisitions (M&A) and securities counsel to numerous national companies and private equity firms, Ryan Thomas has closed over $60 billion in M&A transactions, and approximately $80 billion in overall transactions, including both the largest domestic LBO, and the largest private equity-backed IPO at the time. Ryan’s practice focuses on public and private companies within the healthcare, media, retail, government services, life sciences and technology industries, among others. Ryan also advises management, boards and special committees on shareholder activism, corporate governance and public company disclosure matters.
Ryan’s practice involves:
Ryan has been recognized by various leading outlets, such as Chambers USA and The M&A Advisor, for his work in the M&A and private equity space. In 2021 alone, The M&A Advisor named two of Ryan’s deals as finalists in eight categories for the 2021 M&A Advisor Awards. Over the past few years, several transactions have been named as finalists in multiple categories including:
Ryan is active in the leadership of the ABA’s M&A and Business Law Committees, serving as editor of the Deal Points publication and the executive editor for M&A content of Business Law Today. He has been extensively quoted and published on M&A matters and high profile deals in leading national media such as The Wall Street Journal Pro Private Equity, The Business Lawyer, The Corporate Board, Executive Counsel, Marketwatch.com, Los Angeles Times, TheStreet.com, GlobeSt.com, Associate Press, Bloomberg News and others.
Association for Corporate Growth, Tennessee Chapter — Board Member
American Health Law Association (AHLA)
American Bar Association — Business Law and M&A Committees
Representation of Pharos Capital’s post-acute care provider platform, Charter Health Care Group, in its acquisition of Genesis Hospice, a Texas-based hospice care provider. The addition of Genesis and Saints brings the number of Charter locations to 18 and marks the company’s fourth program in Texas.
Representation of Integrated Polymer Solutions (IPS), an Arcline Investment Management portfolio company and leading manufacturer of custom, highly engineered elastomeric components, in its acquisition of Seal Science, Inc., a designer and manufacturer of engineered elastomeric sealing solutions.
Representation of a founder owned WorkCompEDI and its affiliates, a leading EDI clearinghouse for the Property & Casualty market, in its sale to Data Dimensions, LLC, the leading provider of outsourced document handling and workflow solutions and portfolio company of Thompson Street Capital Partners. The merged companies will operate under the Data Dimensions brand and will leverage their respective strengths to become the premier technology services organization in the P&C industry.
Representation of Health Enterprise Partners (HEP) – a healthcare and technology focused middle milled-market private equity firm – and Providence Ventures – the Venture capital arm of Providence St. Joseph Health (PSJH) and nation’s third largest health system – in its $15 million Series A funding round of Kno2, a healthcare interoperability technology platform.
Representation of Advanced Dermatology and Cosmetic Surgery (ADCS), the largest team of dermatology experts nationwide, in its acquisition of Palmetto Dermatology, a South Carolina-based dermatology practice. This acquisition expands ADCS’ national footprint to approximately 140 offices nationwide and this marks its second South Carolina location.
Representation of Wayspring, formerly Axial Healthcare, in its $75 million investment from Valtruis, Centene Corporation, CareSource, HLM Venture Partners and other leading investors. Wayspring will use the capital to scale its value-based care solution, a full-risk medical home model for substance use disorder (SUD).
Representation of Providence Ventures in a $20 million investment in TailorMed Medical, a leading financial navigation software platform. Providence Ventures led the financing round and was joined by new investors UnityPoint Health Ventures, Almeda Ventures, Bridges Israel and Discount Capital with participation from existing investors Accelmed, Sanara Ventures and Triventures.
Representation of TripleTree, LLC who acted as financial advisor to Icario in its recapitalization by CVC Capital Partners, a leading private equity and investment advisory firm.
Representation of Humana Innovation Enterprises Inc. (affiliated with Humana Inc.) in its minority joint venture investment in Summit Medical Group, East Tennessee’s largest primary care organization.
Chambers USA — Corporate/M&A (2019-2021), Recognized Practitioner (2017-2018)
M&A Advisor — Finalist (2021):
Who’s Who Legal — Corporate: Corporate Governance (2018-2021); Corporate: Mergers & Acquisitions (2018-2021)
Acritas Stars — Independently Rated Lawyer (2019-2020)
IFLR1000 — Notable Practitioner (2019-2021)
M&A Advisor — Winner (2019):
M&A Advisor — Finalist (2019):
M&A Advisor — “M&A Deal of the Year” Finalist (2015)
M&A Advisor — “40 Under 40” Finalist (2012)
M&A Advisor — “M&A Deal of the Year” (2012)
Mid-South Super Lawyers “Rising Star” (2011-2014)
Vanderbilt Journal of Transnational Law — Editor
Phi Beta Kappa